BNET Industries
Amazon Biotech Inc. (AMZO) is in the Pharma Industry
- Profit
- Jul 31 2007
- ($1.6M)
- Market Cap
- Oct 06 2008
- $341.9K
Latest News and Analysis
Amazon Biotech Announces Filing of 14A to Set Shareholder Meeting
Amazon Biotech, Inc. (PINKSHEETS: AMZO)(FRANKFURT: B2DA) announced that a preliminary 14A was filed by Amazon toset a shareholder meeting, at a time to be announced, to elect a threemember Board of Directors and to address such other matters as may properlycome before the meeting or any adjournments thereof. Amazon Biotech,...
Amazon Biotech Announces Filing of 14A to Set Shareholder Meeting
Amazon Biotech, Inc. (PINKSHEETS: AMZO)(FRANKFURT: B2DA) announced that a 14A was filed by Amazon setting ashareholder meeting for July 18, 2008, to elect a three member Board ofDirectors and to address such other matters as may properly come before themeeting or any adjournments thereof. The entire 14A filing...
Amazon Biotech Informs Shareholders of Unauthorized 8K Filing
Amazon Biotech, Inc. (OTCBB: AMZO) (FRANKFURT: B2DA) announced that an 8K was filed by Amazon's former employee, MichaelKanovsky, on June 13, 2008, alleging that a written consent of the Board ofDirectors issuing shares as compensation in lieu of debt owed to a creditorof the company was never signed...
Amazon Biotech Announces Appointment of Dr. Michael Silver as New Scientific Director
Amazon Biotech, Inc. (OTCBB: AMZO) (FRANKFURT: B2DA.F) announced that Dr. Michael Silver has been appointed as thecompany's new Scientific Director. Dr. Silver has over 15 years of experience in the biotechnology,pharmaceutical and medical device industries serving as Director ofBusiness Development and Senior Scientist at Bio-Imaging Technologies,Inc., as Director of Scientific...
Amazon Biotech Announces Appointment of New CEO and New Corporate Counsel
Amazon Biotech, Inc. (OTCBB: AMZO) (FRANKFURT: B2DA) announced that Mr. Eliyahu BenTal Tolchinsky has been appointed asdirector and Chief Executive Officer of the Company. Mr. Tolchinsky, a graduate of Cornell University and Tulane Law School, hasa strong background in Research and Development, intellectual propertyprotection and regulatory compliance. Mr. Tolchinsky has...
Amazon Biotech, Inc. Issues Shareholder Update of Corporate Developments
Amazon Biotech, Inc. (OTCBB: AMZO)(FRANKFURT: B2D) has released the following update to shareholders: In the past six months, Amazon Biotech, Inc. has raised $215,000 in capitaland is in negotiations for a further $2.3 Million. Upon the successfulcompletion of funding the Company will focus on initiating phase I/IItrials for its AIDS...
Solar Energy Market is Booming!!
M2 PRESSWIRE-6 June 2007-LiquidStockReport.com: Solar Energy Market is Booming!!C1994-2007 M2 COMMUNICATIONS LTD RDATE:06062007 Stocks to Watch: Open Energy Corporation (OTCBB: OEGY) , Dhanoa Minerals Ltd. (OTC BB:DHNA) , KAL Energy, Inc (OTC BB:KALG) , Oshkosh Truck Corporation (NYSE:OSK) , Amazon Biotech,...
MMUS, OPTM, PNTR, TSTC, AMZB, CYDF Have Also Been Added To Naked Short List Today.
M2 PRESSWIRE-22 May 2007-BUYINS.NET: MMUS, OPTM, PNTR, TSTC, AMZB, CYDF Have Also Been Added To Naked Short List TodayC1994-2007 M2 COMMUNICATIONS LTD RDATE:22052007 BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked...
Daily Market Movers Digest Report for Tuesday, April 3rd AMZB, UCSY, REAL, ETIM, GPSN.
M2 PRESSWIRE-3 April 2007-OTCPicks.com: Daily Market Movers Digest Report for Tuesday, April 3rd AMZB, UCSY, REAL, ETIM, GPSNC1994-2007 M2 COMMUNICATIONS LTD RDATE:03042007 Our Stocks to Watch today include Amazon Biotech (OTCBB: AMZB), Universal Communication Systems (OTC: UCSY), Reliability Inc (OTC: ...
Speak with other shareholders about: (OTCBB: AMZB), (OTC: UCSY), (OTC: REAL), (OTC: ETIM), (OTCBB: GPSN).
M2 PRESSWIRE-3 April 2007-Stockwire.com: Speak with other shareholders about: (OTCBB: AMZB), (OTC: UCSY), (OTC: REAL), (OTC: ETIM), (OTCBB: GPSN)C1994-2007 M2 COMMUNICATIONS LTD RDATE:03042007 AUSTIN, TX: A very interesting indicator to look for is where the money is flowing into. We have...
(OTC BB: AMZB) in Early Negotiations With Major Pharmaceutical Companies
Amazon Biotech, Inc. (OTCBB: AMZB)(FRANKFURT: B2D) announced that it has secured the services of Mr. StanleyFass to negotiate a joint venture agreement between Amazon Biotech andmajor pharmaceutical companies. For more information, go to http://biz.yahoo.com/iw/070330/0232802.html For a Free Newsletter, go to http://www.OTCReporter.com Other active stocks are Level...
PLMA, PVNC, GBDX, NIHK, AMZB "Red Hot Penny Stock Alert".
M2 PRESSWIRE-2 April 2007-redhotpennystock.com: PLMA, PVNC, GBDX, NIHK, AMZB "Red Hot Penny Stock Alert"C1994-2007 M2 COMMUNICATIONS LTD RDATE:02042007 Bull in Advantage, LLC a.k.a. Redhotpennystock.com names Palomar Enterprises, Inc. (OTCBB: PLMA), Prevention Insurance (OTCBB: PVNC), Global Diamond Exchange (Pink Sheets: GBDX),...
Amazon Biotech Inc. in Early Negotiations With Major Pharmaceutical Companies
Amazon Biotech, Inc. (OTC BB: AMZB) (FRANKFURT: B2D) announced that it has secured the services of Mr. Stanley Fass tonegotiate a joint venture agreement between Amazon Biotech and major pharmaceutical companies. Amazon Biotech has entered in negotiations with major pharmaceuticalcompanies for funding of future studies and marketing of the company'santi-HIV...
Patent Issued: Spurs Review: Sector Specific.
M2 PRESSWIRE-26 March 2007-Pinnacle Digest: Patent Issued: Spurs Review: Sector SpecificC1994-2007 M2 COMMUNICATIONS LTD RDATE:26032007 To read this article in its entirety, visit www.pinnacledigest.com. Amazon Biotech, Inc. (OTCBB: AMZB) experienced an even day of trading Friday combined with 213,000...
With Patent in Hand and an Encouraging Analyst Report, Amazon Biotech Is Moving Forward With Its Phase I/II Clinical Trial Preparations
Amazon Biotech, Inc. (OTCBB: AMZB) (FRANKFURT: B2D) has been issued a patent from the United States Patent and TrademarkOffice, patent # 7,160,561 for "a herbal composition and method of treatingHIV infection." AMZ0026, a therapeutic herbal composition, is Amazon Biotech's primary drugcandidate and is currently approved by the FDA to undergo...
(OTC BB: AMZB) Moving Forward With Its Phase I/II Clinical Trial Preparations
Amazon Biotech, Inc. (OTCBB: AMZB)(FRANKFURT: B2D) has been issued a patent from the United States Patent andTrademark Office for a herbal composition and method of treating HIVinfection. For more information, go to http://biz.yahoo.com/iw/070226/0219789.html For a Free Newsletter, go to http://www.OTCReporter.com Other active stocks are Arris Group...
StockPromoters.com Announces Its Latest Results, Highlighting the Best Deals for Wednesday, February 21, 2007!
StockPromoters.com has ranked allrecent promotional campaigns by performance and has compiledthe following list of winners by stock and promoter. Amazon Biotech, Inc. (OTCBB: AMZB) showed an increase fromits average 3-month trading volume of about 286,000 sharesto over 2,849,696 with a subsequent intraday rise in stockprice of about 18 percent. ...
Harbinger Research Issues Research Brief for Amazon Biotech Inc.
M2 PRESSWIRE-20 February 2007-Early Watch: Harbinger Research Issues Research Brief for Amazon Biotech Inc.C1994-2007 M2 COMMUNICATIONS LTD RDATE:20022007 Amazon Biotech, Inc.(OTC BB:AMZB) is a natural plant pharmaceutical company, primarily developing immune modulator drugs. AMZ0026 is the company's first such drug,...
OTCPicks.com Daily Market Movers Digest Midday Report for Tuesday, February 20th, AMZB, VSPC, SBJX, NPWS, NTTL, WITM.
M2 PRESSWIRE-20 February 2007-OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday Report for Tuesday, February 20th, AMZB, VSPC, SBJX, NPWS, NTTL, WITMC1994-2007 M2 COMMUNICATIONS LTD RDATE:20022007 Our Stocks to Watch today include Amazon Biotech, Inc. (OTCBB: AMZB), VIASPACE, Inc. (OTCBB: VSPC), Subjex...
Speak with other shareholders about: (OTC: SGCP), Globex, Inc. (OTC: GLXI), Wits Basin Precious Minerals Inc. (OTCBB: WITM), Amazon Biotech, Inc. (OTCBB: AMZB).
M2 PRESSWIRE-20 February 2007-Stockwire.com: Speak with other shareholders about: (OTC: SGCP), Globex, Inc. (OTC: GLXI), Wits Basin Precious Minerals Inc. (OTCBB: WITM), Amazon Biotech, Inc. (OTCBB: AMZB).C1994-2007 M2 COMMUNICATIONS LTD RDATE:20022007 AUSTIN -- A very interesting indicator to look for is...
- Next »
- page 1 of 1
- « Previous
- Incorporated: 2002
- CEO: Mr. Mechael Kanovsky
Amazon Biotech is a development stage company that was established to focus on the research and development of novel all-natural drugs for a better quality of life by using the best of traditional medicines from nature. Co.'s goal is to be a world leader and contributor in the treatment of HIV/AIDS naturally through the use of immune-based therapies. An immune-based therapy is defined as any treatment geared toward reestablishing proper functioning of the immune system or directly helping the immune system to fight a virus, e.g. HIV/AIDS. Co. has developed a product called AMZ 0026, which has an FDA approved IND procedure for Phase I/II clinical studies for HIV/AIDS.
Key Competitors
Amazon Biotech Inc. Company Info
Board of Directors
Mr. Eliyahu Bental Tolchinsky
Mr. Simcha Edell
Mr. Mechael Kanovsky
Contact Information
43 West 33rd Street, Suite 405
New York, NY
212 947-3362
NAICS Code
Pharmaceutical Preparation Manufacturing: 325412
